Dr. Jeffrey Warren Allen, MD Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1440 E Mullan Ave, Post Falls, ID 83854 Phone: 208-625-4900 Fax: 208-625-4901 |
Dr. Kevin Patrick Mulvey, MD Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1440 E Mullan Ave, Post Falls, ID 83854 Phone: 208-619-4100 |
News Archive
Adamas Pharmaceuticals, Inc., a privately held company, announced today that it has entered into a Cooperative Research and Development Agreement (CRADA) with the United States Naval Health Research Center for preclinical studies evaluating Adamas' triple combination antiviral drug (TCAD) therapy for influenza A, including novel influenza A/H1N1. TCAD therapy includes Adamas' investigational proprietary fixed-dose oral combination drug, to be administered adjunctively with a neuraminidase inhibitor, including Tamiflu (oseltamivir phosphate, Roche).
IQuum, Inc. announced today that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance to market the Liat Influenza A/B Assay and the Liat Analyzer.
The "Young Scholars Network on Media Use and Well-Being" brings together the expertise of 15 international young researchers exploring the benefits and risks associated with the use of media and their effects on psychological well-being over a three-year period.
The discovery of an unusual hepatitis B virus from shrews offers new opportunities of better understanding the chronic progression of the disease. International research teams were able to demonstrate that an important protein which is essential for the development of a chronic course of infection is not present in this virus.
The heart cannot regenerate muscle tissue after a heart attack has killed part of the muscle wall, and that dead tissue can strain surrounding muscle, leading to a lethal heart enlargement.
› Verified 3 days ago